Introduction
Alzheimer's disease (AD) typically presents with deficits in learning new information as well as in retrieving old memories (B€ ackman et al., 2001) . This loss in long-term episodic memory has been referred not only to local damage of the medial temporal lobes, but also to a dysfunction of large-scale networks underlying memory processes. Since the early stages of AD, prominent neuropathological abnormalities (i.e., β-amyloid plaques and neurofibrillary tangles) are known to affect the posterior cortical regions of the brain, including the precuneus (PC), the posterior cingulate, the retrosplenial, and lateral posterior parietal cortex (PPC) . These abnormalities are paralleled by an initial disruption of medial fronto-parietal functional connectivity, as revealed by alterations of the so-called default mode network (DMN), for which the PC is a key node (Buckner et al., 2008; Raichle et al., 2001) . The disconnection of the PC precedes (and probably contributes to) the occurrence of regional brain atrophy, which becomes prominent at later disease stages (Gili et al., 2011) . Indeed, AD patients often show a reduction of PC cortical thickness accompanied by an abnormal activity during memory task performance, and a decrease in functional connectivity . This is relevant since the activity of the PC is considered necessary for episodic memory retrieval (Lundstrom et al., 2005; Wagner et al., 2005) . Therefore, the PC is a vulnerable region for the transitional stage towards dementia, and might represent an ideal target for tailored interventions aimed at counteracting AD-related memory decline.
So far, the only approved treatment for AD is based on cholinergic and glutamatergic drugs. Yet, these drugs have negligible efficacy on memory deficits, and alternative strategies are needed to improve memory in patients with AD (Canter et al., 2016) . Recently, non-invasive brain stimulation methods have been proposed as a novel approach to improve some cognitive performances in patients with dementia (Cotelli et al., 2006 (Cotelli et al., , 2008 Ferrucci et al., 2008; Turriziani et al., 2012) and in healthy volunteers (Casula et al., 2017a; Rastogi et al., 2017) . These studies provided evidence that repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex (DLPFC) may transiently improve language functions, such as naming and sentence comprehension (Cotelli et al., 2011) . More recently, other studies applied rTMS over different brain areas involved in the cognitive decline of AD patients (i.e. right and left DLPFC, right and left posterior parietal cortex (PPC) associative areas, and Broca and Wernicke language areas) in combination with adapted cognitive training (Bentwich et al., 2011) . These studies showed promising results in terms of global cognitive functions as indexed by the improvement of the ADAS-Cog score after 5 weeks of treatment (Nguyen et al., 2017; Rabey et al., 2013) . However, this approach did not show any specific effect on memory functions.
Here we tested the hypothesis that rTMS of the precuneus (PC) may be a novel target to treat memory dysfunction in AD patients. This finds support in recent evidence showing that rTMS applied to key nodes of the DMN such as the PPC (Wang et al., 2014; Nilakantan et al., 2017) and PC (Rose et al., 2016; Bonnì et al., 2015) improves short and long-term memory functions in healthy individuals. Moreover, we recently demonstrated that rTMS of the PC exerts its effects not only at local but also at a network level by modulating the activity of the PC and its connections to other brain areas (Mancini et al., 2017) . Therefore, we hypothesized that high-frequency excitatory rTMS of the PC might improve long-term memory in patients with AD, by modulating the neural activity of the PC and its connections with medial parietal and frontal areas. To evaluate the neurophysiological modifications induced by rTMS and potentially underpinning behavioral changes, we used single-pulse TMS combined with EEG recordings.
Materials and methods

Experimental design and participants
The current study was approved by the Ethical Committee of Santa Lucia Foundation (Protocol number: CE/PROG.465). Written informed consent was obtained from all patients before entering the study. Neuronavigated rTMS was used to stimulate the PC of AD patients for two weeks in a sham-controlled crossover design. Thirty patients, admitted to the Specialist Memory Clinics of "Tor Vergata" University (Rome, Italy) and Catholic University of Rome (Rome, Italy) between January 2014 and June 2016 for complaining of memory symptoms, were screened for the current study. Patients' recruitment was performed according to current diagnostic criteria for prodromal AD (Dubois et al., 2016) , referring to the early symptomatic phase of AD, characterized by episodic memory loss in the presence of AD pathology as supported by CSF or imaging biomarker evidence. All AD patients had to be cognitively intact before the occurrence of cognitive impairment. Subjective memory impairment, corroborated by an informed caregiver had to occur at least 12 months earlier. After the first visit, patients underwent, for diagnostic purposes, a complete clinical investigation, including medical history and neurological examination, a complete blood screening, a neuropsychiatric evaluation, brain MRI scanning, and an extensive neuropsychological assessment exploring all cognitive domains (Table 1) . Lumbar puncture was performed in all patients to confirm the typical CSF profile of AD pathology, i.e., reduced concentrations of amyloid β 1-42 , increased levels of total-and phosphorylated-tau. Major systemic and psychiatric disorders, other neurological conditions, and signs of concomitant cerebrovascular disease on MRI scans were carefully investigated and excluded in all patients. Patients who agreed to participate (N ¼ 14; see Table 2 ) were randomly assigned to rTMS or sham as their first experimental arm belonging. The order of administration of either intervention (i.e., rTMS or sham) was counterbalanced across all patients. rTMS (or sham) was applied daily, at the same day-time, in a 10 session course, Monday to Friday. A two-week washout interval was applied before patients were crossed over to either experimental arm for two more weeks. Neuropsychological and neurophysiological evaluations, the latter performed by combining TMS and EEG, were performed on the Monday morning before and after each of the two week-treatment (rTMS or sham). All researchers performing patients' evaluations were blind to their experimental arm belonging. Details of the study design are summarized in Fig. 1A . stimuli: 1600). The entire session lasted approximately 20 min. Intensity of stimulation was set at 100% of the resting motor threshold (RMT), defined as the lowest intensity producing MEPs of >50 μV in at least five out of 10 trials in the relaxed first dorsal intereosseous (FDI) muscle of the right hand (Rossini et al., 2015) . RMT was assessed over the optimal stimulus site to elicit MEPs in the right FDI, termed "motor hotspot", identified by positioning the coil approximately over the central sulcus and moving it on the scalp by 0.5 cm steps on left M1. During the rTMS treatment, the coil was positioned over the PC and constantly monitored using the Softaxic neuronavigation system (EMS, Bologna, Italy) coupled with a Polaris Vicra infrared camera (NDI, Waterloo, Canada). Individual T1-weighted MRI volumes were used as anatomical reference (Fig. 1B) . Since the coil-to-cortex distance directly affects the magnitude of magnetic stimulation, for each patient we calculated a distance-adjusted MT (AdjMT). AdjMT¼MT þ mÂ(DsiteXÀDM1), where AdjMT is the adjusted MT in % of stimulator output, MT is the unadjusted MT in % of stimulator output, DM1 is the distance between the scalp and M1 hotspot, DSiteX is the distance between the scalp and a second cortical region (SiteX), and m is the distance-effect gradient. This procedure provides a more accurate index of cortical excitability and improves the efficacy of MT-calibrated TMS (Stokes et al., 2005) . Coil orientation was parallel to the midline with the handle pointing downward. For sham treatment, stimulation was applied using the same parameters with the sham coil positioned to the scalp in correspondence to the target area. For each patient, a source estimation on pre-processed TMS-EEG data was run at the beginning of each treatment session to confirm the correct anatomical targeting for rTMS. were randomly assigned to either a first neuronavigated rTMS or control stimulation (sham) arm. rTMS/sham was daily applied in a 10-session course, Monday to Friday, for a total duration of two weeks. A two-week washout interval was then applied, following which patients were crossed over to the alternative study arm for two additional weeks. The order of assignment to either study arm was counterbalanced across patients. (B) rTMS was applied over the PC at 20 Hz (1600 stimuli per day), using a neuronavigation system to ensure that the same spot was constantly stimulated across sessions. (C) Source analysis of TMS-evoked EEG activity showed a bilateral activation of the PC, as reconstructed at the peak fit of cortical response between 60 and 90 ms from PC stimulation with single-pulse TMS.
Intervention -repetitive TMS
Cognitive evaluations
To evaluate the behavioural effects of the rTMS treatment, we employed a battery of tests assessing long-term episodic memory, executive functions, attention, and global cognition, according to the Alzheimer Disease Cooperative Study Preclinical Alzheimer Cognitive Composite (ADCS-PACC) (Donohue et al., 2014) . This battery is a well-known clinical instrument with high sensitivity to cognitive decline in prodromal and mild dementia, and with a sufficient range to detect early decline in preclinical disease stages. The battery includes: 1) the immediate and delayed total recall score from the Rey Auditory Verbal Learning test (RAVLT), to evaluate long-term episodic memory; 2) the Digit Symbol Substitution Test (DSST) from the Wechsler Adult Intelligence Scale-Revised, to evaluate response speed, sustained attention, visual-spatial skills, and set-shifting; 3) the Mini Mental State Examination (MMSE), to evaluate global cognition, and 4) the Frontal Assessment Battery (FAB), to evaluate executive functions.
EEG recordings
EEG was performed using a TMS-compatible EEG equipment (BrainAmp 32MRplus, BrainProducts GmbH, Munich, Germany), and was continuously recorded from 29 scalp sites positioned according to the 10-20 International System. TMS-compatible Ag/AgCl pellet electrodes were mounted on an elastic cap, while additional electrodes were used as ground and reference. Horizontal and vertical eye movements were detected by recording the electrooculogram (EOG) to off-line reject trials showing ocular artifacts. The ground electrode was positioned in AFz, while the reference one was positioned on the nose tip. The EEG and EOG signals were band-pass filtered at 0.1-1000 Hz and digitized at a sampling rate of 5 kHz. Skin/electrode impedance was maintained below 5 kΩ.
Resting EEG
Resting EEG was recorded before each TMS/EEG session for 3 min with open eyes. As a first step, data were downsampled to 1000 Hz and band-pass filtered between 1 and 80 Hz (Butterworth zero phase filters). A 50 Hz notch filter was also applied to reduce noise from electrical sources. Identification and removal of artifacts (muscle activity, eye movements and blink-related activity) was made with independent component analysis (INFOMAX-ICA). Then, signal was segmented in 2-sec epochs. Power density was estimated by means of the Fast Fourier Transform (10% Hanning-window) from 4 to 45 Hz, with a frequency resolution of 0.5 Hz. For each participant, frequency bands were established based on two subjective anchor frequencies, which is the theta/ alpha transition frequency (TF) and the individual alpha frequency (IAF) peak (Klimesch, 1997) . The TF represents the minimum power in the alpha frequency range, whereas the IAF represents the frequency with the maximum power peak within the alpha range (7-12 Hz). Based on TF and IAF, we estimated the frequency band range for each participant, as follows: delta, from TF-4 to TF-2; theta, from TF-2 to TF; low alpha, from TF to IAF; high alpha, from IAF to IAFþ2. For the estimation of individual beta and gamma frequencies we detected three peaks in the frequency range from IAFþ2 to 45 Hz, these peaks were named beta1, beta2 and gamma peak. Low beta range was computed from IAFþ2 to the lower spectral power between beta1 and beta2 peak; high beta range was computed from beta 1 to the lower spectra value power between beta 2 and gamma peak; gamma range was computed from beta 2 to 45 Hz. The mean band power was then obtained by averaging the power values of all the single-trial epochs for each participant.
TMS/EEG
To evaluate the neurophysiological modifications induced by rTMS and potentially underpinning behavioral changes, we used single-pulse TMS combined with EEG recordings. During all neurophysiological evaluations, patients were seated on a dedicated, comfortable armchair in a soundproof room. Each neurophysiological assessment began with a TMS-EEG session to evaluate the cortical excitability and the oscillatory activity evoked by single-pulse TMS. Single-pulse TMS was carried out using a Magstim Rapid 2 magnetic biphasic stimulator connected with a figure-of-eight coil with a 50-mm diameter (Magstim Company, Whitland, UK). Each TMS-EEG session consisted of 80 single pulses applied at a random inter-stimulus interval (ISI) of 2-4sec. TMS-EEG was applied over the PC, which was the target of the rTMS intervention, and over the left posterior parietal cortex (l-PPC). Importantly, we chose to stimulate the l-PPC as a control site for its proximity to the PC, since we want to assess the spatial specificity of our rTMS intervention. The order of stimulation of either area was counterbalanced across patients. The intensity of stimulation of single-pulse TMS was set at 90% of the AdjMT (PC: 57.8 AE 3.1; l-PPC: 54.2 AE 2.6). A short break was run between TMS-EEG stimulation of either site. The coil was differently oriented respect to the mid-sagittal axis of the patient's head, for each stimulation site: parallel over the PC, at 15 over l-PPC, with the handle pointing backward. The coil position was constantly monitored using the Softaxic neuronavigation system, to ensure a high degree of reproducibility across neurophysiological assessments. TMS-EEG data were preprocessed offline using Brain Vision Analyzer (Brain Products GmbH, Munich, Germany). TMS-EEG data were analyzed offline with Brain Vision Analyzer (Brain Products GmbH, Munich, Germany) and EEGLAB toolbox running in a MATLAB environment (MathWorks Inc., Natick, USA; Delorme and Makeig, 2004) . As a first step, a cubic interpolation from 1 ms before to 10 ms after the TMS pulse was applied to remove the TMS artifact. Afterwards, the signal was downsampled and filtered as on the resting EEG data. Physiological and TMS-related artefactual components were detected using INFOMAX-ICA and removed basing on their scalp distribution, frequency, timing and amplitude (Casula et al., 2017b) . Data were then segmented into epochs starting 1 s before the TMS pulse and ending 1 s after it. Afterwards, all the epochs were visually inspected and those with excessively noisy EEG were excluded from the analysis, resulting 68.7 AE 2.9 in the pre-rTMS condition, 68.9 AE 2.9 in the post-rTMS, 70.7 AE 2 in the pre-sham, 70.1 AE 2.1 in the post-sham, stimulating the PC. For l-PPC stimulation, we used 76.5 AE 1.1 trials in the pre-real condition, 76.1 AE 1.9 in the post-real, 76.4 AE 0.8 in the pre-sham, 76.9 AE 1.4 in the post-sham.
Two sets of outcome measures were obtained, assessing, respectively, cortical excitability (using a spatio/temporal-domain analysis) and cortical oscillatory activity (using a time/frequency-domain analysis). To evaluate changes in cortical excitability, we evaluated both, global and local cortical responses evoked by TMS. The global response was assessed, for each patient and each stimulation site (PC and l-PPC), by measuring the first five peaks (10-35 ms for P1; 36-62 ms for P2; 63-90 ms for P3; 91-165 ms for P4 and 166-250 ms for P5) of the global mean field power (GMFP) waveform within the 300 msec following the TMS pulse. Local responses were measured by the TMS-evoked potentials (TEPs) waveform at each electrode within the five temporal windows used for GMFP analysis.
To evaluate changes in the oscillatory domain, we performed a time/ frequency decomposition based on Morlet wavelet (parameters c ¼ 3; 41 linear 1 Hz steps from 4 to 45 Hz), and then we computed event-related spectral perturbation (ERSP) and inter-trial coherence (ITC). ERSP is a measure of event-related changes in spectral power over time in a certain frequency range computed as:
where, for n trials, the spectral estimate F was computed at trial k, at frequency f and time t. ITC is a measure of the partial or exact synchronization of activity at a particular latency and frequency to an experimental event to which EEG data trials are time locked (i.e. TMS pulse), computed as:
F k ðf ; tÞ jF k ðf ; tÞj ITC coefficient takes value between 0 and 1, where 0 represents absence of synchronization between EEG data and the time-locked event and 1 represents their perfect synchronization. Analysis of ERSP values was conducted over five regions of interest (ROI), each one comprising three electrodes: frontal ROI (F3, Fz, F4); central ROI (C3, Cz, C4); parietal ROI (P3, Pz, P4); left ROI (F7, T7, P7) and right ROI (F8, T8, P8). To minimize the effect of possible artifacts occurring at the time of stimulation, the frequency values were averaged over a 20-250 ms time window from the TMS pulse, corresponding to the timing of the oscillatory activity. The spectral power was computed in the frequency ranges between 4 and 7 Hz (theta), 8-13 Hz (alpha), 14-30 Hz (beta) and 31-45 Hz (gamma).
Statistical analysis
To assess the effect of rTMS on patients' performance at RAVLT, a repeated-measures ANOVA with treatment (rTMS or sham) and time (pre-or post-treatment) as factors was performed. The same test was used to assess changes in the patients' performance at all tests included in the ADCS-PACC, to ensure that the improvement induced by rTMS was specific for episodic memory.
To assess the rTMS effect on the spectral power of resting EEG we used a repeated-measures ANOVA with factors treatment (rTMS and sham) and time (pre-and post-treatment) separately conducted for each frequency band (delta, theta, low alfa, high alfa, low beta, high beta and gamma). Effects on amplitude of GMFP peaks (global response) were measured with a repeated-measures ANOVA with factors treatment (rTMS and sham), time (pre-and post-treatment) and peak (P1, P2, P3, P4, P5) performed separately for the two stimulation sites (PC or l-PPC).
To assess the treatment effects on local cortical response over the PC and the l-PPC, we used multiple dependent t-tests comparing TEPs waveform at each electrode within the five temporal windows used for GMFP analysis. Non-parametric, cluster-based permutation statistics was conducted to correct for multiple comparisons (Maris and Oostenveld, 2007) . This method performs a non-parametric statistical test by calculating Monte Carlo estimate of the significance probabilities from two surrogate distributions constructed by randomly permuting the two original conditions data for 3000 times (Casula et al., 2017c) . The clusters for permutation analysis were defined as the two (or more) neighboring electrodes in which the t-value at a given time point exceeded a threshold of P < .05.
A repeated-measures ANOVA with factors region-of-interest (frontal, central, parietal, left, right), treatment (rTMS or sham) and time (pre-or post-treatment) was performed to evaluate the rTMS effects on oscillatory activity (ERSP), separately for each frequency band. Analysis of ITC was conducted on the beta-band activity (14-30 Hz) considering the electrode over the stimulation site, i.e., Pz for the PC and P3 for l-PPC. A repeated-measures ANOVA with treatment (rTMS or sham) and time (pre-or post-treatment) as factors was performed to evaluate the effects of rTMS on ITC beta-band activity.
For all the ANOVA procedures, the Huynh-Feldt ε correction factor was applied where appropriate to compensate for effects of nonsphericity. Bonferroni's correction was applied to post-hoc comparisons.
Source analysis
In order to confirm the targeting of the stimulation, as a preliminary analysis, we used source estimation on the pre-processed TMS-EEG data at the beginning of the treatment for each subject. Briefly, using BrainStorm software we estimated the activity of the dipoles underlying the brain electrical activity, by means of the ICBM152 template (Tadel et al., 2011) . Since this kind of inverse problem presents an infinite number of dipole patterns that could generate the same electrical activity registered by the electrodes, we used minimum norm imaging to approach the forward modelling. As a preliminary step, this method finds a cortical current source density distribution that can approximate the data, and then defines the solution with the minimum energy, using source covariance. We modelled one dipole at each grid point, normally oriented to the cortical surface. We then used the standardized low-resolution brain electromagnetic tomography (sLORETA) measure to normalize the current density map at each point (Pascual-Marqui et al., 2002) . The estimated source distribution was averaged across the patients (Supplementary Movie 1) and the PC was selected as region of interest using the definition of the Desikan-Killiany atlas (Desikan et al., 2006) .
Supplementary video related to this article can be found at https:// doi.org/10.1016/j.neuroimage.2017.12.048.
Behavioral-neurophysiological correlations
In order to investigate possible relationships between clinical and neurophysiological outcomes, we tested correlations using the Pearson's coefficient (two-tailed) between the modulations observed in the RAVLT and in the GMFP.
Results
Fourteen patients with AD (F/M ¼ 7/7) took part in the study, which was conducted between January 2014 and June 2016. Demographic and clinical characteristics of the cohort are summarized in Table 1 . They all completed the protocol successfully, attending all experimental sessions.
Source analysis
The source analysis of TMS-evoked EEG activity showed that the response was spatially distributed along the wall of the medial superior parietal cortex bilaterally, corresponding to the PC (Movie 1) (Bzdok et al., 2015) . This confirmed, in all participants, a correct anatomical identification of the stimulation site (Fig. 1C) . The Montreal Neurological Institute (MNI) coordinates of the stimulation site averaged across participants were [x,y,z] ¼ [0,-65 AE 2,37 AE 9]. The mean scalp-to-cortex distance for the PC was 27 AE 0.3 mm, and the AdjMT for rTMS was 60.8 AE 3.1% of maximum stimulator output.
Cognitive evaluation
ANOVA on the performance at Delayed Recall of the Rey Auditory Verbal learning Test showed a significant time Â treatment interaction [F (1.13) ¼ 5.98; p ¼ .029] (Fig. 2) . Post-hoc analysis revealed a significant improvement at the test performance after rTMS (post-hoc p ¼ .02). No significant effects were detected after sham stimulation (post-hoc p > .05). No significant effects were observed on patients' executive functions, attention or global cognition (all ps > 0.05, Table 3 ).
Resting EEG
ANOVAs performed on the mean spectral power for each frequency band, did not reveal any significant main effect of rTMS (all ps > 0.05), time (all ps > 0.05), nor any significant interaction between the two factors (all ps > 0.05).
TMS-evoked cortical activity
ANOVA performed on mean TMS-evoked activity evaluated over PC revealed a significant rTMS Â time Â peak interaction [F (4.52) ¼ 5.74; p ¼ .0006], due to a significant increase of P3 after real rTMS treatment (Fig. 3a) . Post-hoc analysis showed for P3 a significant difference between pre and post real rTMS treatment (p ¼ .008), and between post real and post sham (p ¼ .005). For all peaks, no significant differences were observed between baseline of each rTMS treatment (all ps > 0.05) and between pre and post sham rTMS (p > .05, Fig. 3b) . No significant effects were found when stimulating l-PPC indicating that the rTMS protocol was unable to induce a general effects on cortical excitability of surrounding cortical sites ( Fig. 3c and d) . When stimulating the PC, the cluster-based analysis did not reveal any significant difference between the baselines of the two groups (i.e. pre-sham rTMS vs. pre-real TMS; Monte Carlo p > .05). As revealed by TEPs and GMFP amplitude, PCrTMS produced a significant increase of TMS-evoked activity from PC over a specific time window, i.e. from 60 to 90 ms after TMS over two distinct cluster of electrodes: one frontal, comprising Fz, FC2 and F4 electrodes; and one parieto-occipital, comprising Pz, O1 and O2 (MonteCarlo p < .01). No difference was detected after sham stimulation, nor after stimulation of l-PPC (Monte-Carlo p > .05).
TMS-evoked oscillatory activity
ANOVA performed on mean ERSP values evaluated over PC revealed a significant ROI Â rTMS Â time interaction when beta oscillatory activity was evaluated [F (4.52) ¼ 3.093; p ¼ .023]. Post-hoc analysis showed a significant increase of beta activity over the parietal ROI in the postrTMS condition compared to pre-(3.565 AE 0.37 vs. 2.257 AE 0.46 μV; p ¼ .021) (Fig. 4a) . No effect was revealed in the sham rTMS condition (Fig. 4b) , nor between the baselines of the two conditions (pre-real rTMS vs. pre-sham rTMS; p > .05). ANOVA did not reveal any significant differences in the other frequency bands (all ps > 0.05) nor when stimulating l-PPC (Fig. 4c,d ).
ANOVA performed on mean ITC values evaluated over PC revealed a significant rTMS Â time interaction when beta oscillatory activity was evaluated [F (1.13) ¼ 11.36; p ¼ .005]. Post-hoc analysis showed a significant increase of beta activity after rTMS condition compared to pre-(0.0006 AE 0.01 vs. 0.007 AE 0.01; p ¼ .002) (Fig. 5a) . Again, no significant effects were observed after sham treatment (Fig. 5b) nor when stimulating the l-PPC (Fig. 5c,d ).
Behavioral-neurophysiological correlations
Analysis of relationships between clinical and neurophysiological data did not reveal any significant correlation (all ps > 0.05).
Discussion
We evaluated here the usefulness of rTMS in modifying selectively the cognitive performance of patients with typical AD at early clinical stages. In our patient sample, we demonstrated a significant beneficial effect of this intervention in improving episodic memory. Our neurophysiological data suggest that this improvement is underpinned by changes in cortical activity of the PC and its connectivity with frontal areas. rTMS induced an average increase of 0.8 recalled items (36%) at RAVLT (delayed recall). These results provide the first evidence that rTMS could be used as a non-pharmacological intervention to counteract memory loss in AD. The study design was rigorous, with rTMS being sham-controlled in a cross-over design. AD patients, as well as experimenters performing evaluations were blind to the treatment condition at any time of the study -thus minimizing the risk of observing a placebo effect. Despite the sample was relatively small, these results are robust, and could provide the basis for planning a clinical trial with a betweengroup design aimed at evaluating the potential beneficial effects of rTMS of the PC in slowing cognitive decline when applied during a longer period (i.e. six months).
In all AD patients, rTMS delivery on the PC was strictly verified in terms of anatomical localization by a source reconstruction analysis of TMS-evoked EEG activity, using a neuronavigation system. Critically, cognitive evaluations were constantly paralleled by TMS-EEG monitoring, thus allowing a concomitant assessment of the clinical effect of rTMS alongside with information on neurophysiological modulation of the brain. Taken altogether, these findings provide novel evidence that non-invasive treatment of network dysfunction, through stimulation of the PC, represents an effective strategy to enhance long-term memory in AD.
The rTMS-induced improvement of long-term memory reinforces the notion that PC is directly involved in memory dysfunction in prodromal AD (Lundstrom et al., 2005) . With this regard, recent models of long-term memory showed that, in healthy conditions, the encoding of episodic memory is associated with reduced PC activity, while the retrieval is associated with increased PC activity (Daselaar et al., 2009 ). This interaction, which has been termed "the encoding/retrieval flip" (Huijbers et al., 2012) , is reduced in elderly adults with amyloid pathology ( Vannini et al., 2012) . Moreover, memory recall is associated with greater activity in medial regions of the DMN in both healthy subjects and AD patients (Dhanjal and Wise, 2014) . It is therefore plausible that the excitatory rTMS protocol we applied here could have reinforced this memory-related cortical mechanism by increasing PC activity.
From a neurobiological perspective, rTMS could have induced clinical improvement by promoting changes in synaptic plasticity, the most important biological mechanism for learning and memory. Long-term potentiation (LTP) is considered as a main neurophysiological correlate of these cognitive functions (Bliss and Lømo, 1973) . We recently demonstrated that AD patients show a disruption in LTP-like cortical plasticity since early clinical stages (Koch et al., 2012; Di Lorenzo et al., 2016) . In this context, high-frequency rTMS might have induced LTP-like cortical plasticity within the PC of our cohort of AD patients. Consistent with this hypothesis, TMS-EEG analysis revealed a specific increase of PC neural activity. This enhancement was evident not only at a local but also at a network level. Indeed, changes in neural activity were located over two distinct clusters of electrodes: one corresponding to the site of stimulation (PC), one corresponding to the medial frontal cortex, suggesting that rTMS induced relevant modulations over a medial parieto-frontal circuit. Interestingly, the topography of this EEG network resembles the anatomical distribution of the DMN, as identified by functional MRI (Buckner et al., 2008; Raichle et al., 2001 ). We also found that rTMS induced an enhancement of TMS-evoked beta activity, both in terms of power and phase synchronization, focused over the medial parietal electrodes underlying the site of rTMS delivery. Since we applied rTMS at 20 Hz, a frequency that falls within the range of beta oscillations, our results could be explained by a possible long-lasting entrainment of beta-rhythm induced by rTMS (Rosanova et al., 2009) . In this perspective, our findings are in agreement with models proposing beta activity as an efficient cortical frequency through which the brain networks communicate relevant information, playing a pivotal role on different memory processes (Feurra et al., 2016) .
The main limitation of this study is the relatively small sample size. However, in order to select a homogeneous cohort, the clinical diagnosis of AD was supported by the use of CSF biomarkers in all participants, according to the current diagnostic criteria (Dubois et al., 2016) . In addition, the low number of electrodes used for EEG recordings limits the spatial resolution of our conclusions, especially for the source analysis. In spite of these limitations, to our knowledge, this is the first study that investigated both the behavioral and neurophysiological effects of an rTMS protocol in AD patients. From a methodological point of view, we demonstrated the reliability of the TMS-EEG approach in revealing specific cortical changes that were not detectable by the resting EEG analysis.
In conclusion, our results show novel evidence that rTMS may be a potential effective strategy for treating patients with early AD for whom, currently, there is no available therapy. Our work is in line with an emerging framework considering circuit-based dysfunctions as a model for cognitive impairment (Canter et al., 2016) , and identifies the PC as a novel interventional target to successfully improve memory in AD. 
